Advertisement

Outbreaks of Erythematous and Necrotic Papules with Hemorrhagic Crusts

  • Selcen Kundak
  • Malik Ergin
Chapter

Abstract

  • Pityriasis lichenoides (PL) which is also called Mucha-Habermann disease is an uncommon type of self-limited lymphocytic inflammatory dermatosis

  • Pityriasis lichenoides et varioliformis acuta (PLEVA) is one form of PL, presenting with erythematous macules and polymorphic lesions of papules which rapidly evolve into vesicopustular lesions with hemorrhagic and adherent crusts

  • Febrile ulceronecrotic Mucha-Habermann disease (FUMHD) is a rare and severe variant of PLEVA, characterized by aggressive ulceronecrotic skin lesions, high fever and histologically described by features which are typical of PLEVA

  • Erythromycin and tetracyclines are indicated for their anti-inflammatory effects rather than antibiotic effects in treatment of PLEVA

  • In severe PLEVA or FUMHD, immunosuppressive agents may prove to be successful

Keywords

Pityriasis lichenoides Pityriasis lichenoides et varioliformis acuta Febrile ulceronecrotic Mucha-Habermann disease Erythromycin Tetracycline 

References

  1. 1.
    de Castro BAC, Pereira JMM, Meyer RLB, Trindade FM, Pedrosa MS, Piancastelli ACC. Pityriasis lichenoides et varioliformis acuta after influenza vaccine. An Bras Dermatol. 2015;90(3 Suppl 1):181–4.CrossRefGoogle Scholar
  2. 2.
    Markus JR, Carvalho VO, Lima MN, Abagge KT, Nascimento A, Werner B. The relevance of recognizing clinical and morphologic features of pityriasis lichenoides: clinicopathological study of 29 cases. Dermatol Pract Concept. 2013;3(4):7–10.CrossRefGoogle Scholar
  3. 3.
    Virdi S, Kanwar A, Saikia U. Pityriasis lichenoides with ulceronecrosis and hyperthermia: a rare variant of pityriasis lichenoides et varioliformis acuta. Indian J Dermatol Venereol Leprol. 2010;76(2):172–5.CrossRefGoogle Scholar
  4. 4.
    Child Fiona WSJ. Lymphocytic infiltrates. In: Christopher G, Barker J, editors. Rook’s textbook of dermatology. 9th ed. Oxford: Wiley Blackwell; 2016. p. 3685–8.Google Scholar
  5. 5.
    Wood Gary S, Reizner G. Other papulosquamous disorders. In: Bolognia Jean L, Jorizzo JL, Rapini Ronald P, editors. Dermatology. 2nd ed. Edinburgh: Elsevier; 2008. p. 156–61.Google Scholar
  6. 6.
    Pereira N, Brinca A, Manuel Brites M, José Julião M, Tellechea O, Gonçalo M. Pityriasis Lichenoides et Varioliformis Acuta: case report and review of the literature. Case Rep Dermatol. 2012;4(1):61–5.CrossRefGoogle Scholar
  7. 7.
    Lejuste FX, Michaux C, Lehners C, Calteux N. Febrile ulceronecrotic Mucha-Habermann disease. BMJ Case Rep. 2013;2013:bcr2013009739.CrossRefGoogle Scholar
  8. 8.
    Meziane L, Caudron A, Dhaille F, Jourdan M, Dadban A, Lok C, Chaby G. Febrile Ulceronecrotic Mucha-Habermann disease: treatment with infliximab and intravenous immunoglobulins and review of the literature. Dermatology. 2012;225(4):344–8.CrossRefGoogle Scholar
  9. 9.
    Bulur I, Kaya Erdoğan H, Nurhan Saracoglu Z, Arık D. Methotrexate treatment in children with febrile ulceronecrotic Mucha-Habermann disease: case report and literature review. Case Rep Dermatol Med. 2015;2015:357973.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Sotiriou E, Patsatsi A, Tsorova C, Lazaridou E, Sotiriadis D. Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature. Acta Derm Venereol. 2008;88(4):350–5.PubMedGoogle Scholar
  11. 11.
    Alzolibani AA, Zedan K. Macrolides in chronic inflammatory skin disorders. Mediat Inflamm. 2012;2012:159354.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Selcen Kundak
    • 1
  • Malik Ergin
    • 2
  1. 1.Department of DermatologyDr. Behçet Uz Children’s HospitalIzmirTurkey
  2. 2.Department of PathologyDr. Behçet Uz Children’s HospitalİzmirTurkey

Personalised recommendations